title: Risk stratification for secondary prevention with ticagrelor and aspirin: A closer look to patient subsets from the PEGASUS-TIMI 54 trial.
authors: Ferrarotto Hospital, University of Catania, Catania, Italy. Electronic address: dcapodanno@gmail.com.
authors: Davide
authors: D
authors: Capodanno
authors: Ferrarotto Hospital, University of Catania, Catania, Italy.
authors: Piera
authors: P
authors: Capranzano
authors: Ferrarotto Hospital, University of Catania, Catania, Italy.
authors: Sergio
authors: S
authors: Buccheri
authors: Ferrarotto Hospital, University of Catania, Catania, Italy.
authors: Corrado
authors: C
authors: Tamburino
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention / Q000379:methods*; D000077486:Ticagrelor; D016896:Treatment Outcome
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine; D001241:Aspirin
keywords: PEGASUS; Secondary prevention; Ticagrelor